These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 5066667)

  • 1. Clofibrate in coronary heart disease. Effect on morbidity and mortality.
    Krasno LR; Kidera GJ
    JAMA; 1972 Feb; 219(7):845-51. PubMed ID: 5066667
    [No Abstract]   [Full Text] [Related]  

  • 2. Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians.
    Research Committee of the Scottish Society of Physicians
    Br Med J; 1971 Dec; 4(5790):775-84. PubMed ID: 4943606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial of clofibrate in the treatment of ischaemic heart disease. Five-year study by a group of physicians of the Newcastle upon Tyne region.
    Br Med J; 1971 Dec; 4(5790):767-75. PubMed ID: 4943605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clofibrate for prevention of myocardial infarction.
    Med Lett Drugs Ther; 1973 Apr; 15(9):37-8. PubMed ID: 4704699
    [No Abstract]   [Full Text] [Related]  

  • 5. Clofibrate and niacin in coronary heart disease.
    JAMA; 1975 Jan; 231(4):360-81. PubMed ID: 1088963
    [No Abstract]   [Full Text] [Related]  

  • 6. Clofibrate in the treatment and prevention of ischaemic heart disease: recent trials.
    Drug Ther Bull; 1972 Aug; 10(17):65-6. PubMed ID: 4570864
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of cerebrovascular disease with clofibrate. Final report of the Veterans Administration Cooperative Study of Atherosclerosis, Neurology Section.
    Stroke; 1973; 4(4):684-93. PubMed ID: 4723698
    [No Abstract]   [Full Text] [Related]  

  • 8. The coronary drug project--findings with regard to estrogen, dextrothyroxine, clofibrate and niacin.
    Stamler J
    Adv Exp Med Biol; 1977; 82():52-75. PubMed ID: 335823
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of clofibrate on glucide tolerance in patients with ischemic heart disease and hyperlipoproteinemia].
    Bornemisza P; Csögör I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(6):543-6. PubMed ID: 34860
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholesterol, coronaries, clofibrate and death.
    Oliver MF
    N Engl J Med; 1978 Dec; 299(24):1360-2. PubMed ID: 362204
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: After a coronary.
    Br Med J; 1975 Apr; 2(5963):103-5. PubMed ID: 1125693
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term therapy of ischaemic heart disease.
    Dewar HA
    Arzneimittelforschung; 1972 Oct; 22(10):1835-40. PubMed ID: 4630017
    [No Abstract]   [Full Text] [Related]  

  • 13. Impotence in patients treated with clofibrate.
    Schneider J; Kaffarnik H
    Atherosclerosis; 1975; 21(3):455-7. PubMed ID: 50074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperlipemia as a risk factor in ischemic heart disease].
    Hashimoto T; Kobayashi M; Igarashi H; Niitani H
    Nihon Rinsho; 1975 Nov; 33(11):3179-84. PubMed ID: 1107622
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: The value of clofibrate in coronary heart disease.
    Gillam PM
    Am Heart J; 1974 Jan; 87(1):1-4. PubMed ID: 4808754
    [No Abstract]   [Full Text] [Related]  

  • 16. Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials.
    Dewar HA; Oliver MF
    Br Med J; 1971 Dec; 4(5790):784-6. PubMed ID: 4943607
    [No Abstract]   [Full Text] [Related]  

  • 17. Ischemic heart disease: a secondary prevention trial using clofibrate (Atromid-S).
    Oliver MF
    Adv Exp Med Biol; 1972; 26(0):255-9. PubMed ID: 4679687
    [No Abstract]   [Full Text] [Related]  

  • 18. [The serum triglycerides and their role as a coronary risk factor (author's transl)].
    Pristautz H; Pavek P; Klein W
    Z Kardiol; 1977 May; 66(5):216-9. PubMed ID: 878547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group.
    JAMA; 1972 May; 220(7):996-1008. PubMed ID: 4337170
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and metabolic characteristics. Effects on mortality in coronary disease.
    Reynertson RH; Tzagournis M
    Arch Intern Med; 1973 Nov; 132(5):649-53. PubMed ID: 4750221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.